Jingxin Li

2 ta ish

Jiangsu Provincial Center for Disease Control and Prevention

1. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

   Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan +18

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.561376

2. Improved duplex RT-PCR assay for differential diagnosis of mixed infection of duck hepatitis A virus type 1 and type 3 in ducklings

   Linlin Chen, Qian Xu, Ruihua Zhang +6

   Maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.743881